Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Diagnostic and therapeutic challenges in a liver transplant recipient with central nervous system invasive aspergillosis.

Literature DB >> 22676861

Diagnostic and therapeutic challenges in a liver transplant recipient with central nervous system invasive aspergillosis.

Dionissios Neofytos¹, Shmuel Shoham, Kerry Dierberg, Katharine Le, Simon Dufresne, Sean X Zhang, Kieren A Marr.

Abstract

This is a case report of central nervous system (CNS) invasive aspergillosis (IA) in a liver transplant recipient, which illustrates the utility of enzyme-based diagnostic tools for the timely and accurate diagnosis of IA, the treatment challenges and poor outcomes associated with CNS IA in liver transplant recipients.

Entities: Chemical Disease Species

Mesh：

Substances：
Antifungal Agents

Year: 2012 PMID： 22676861 PMCID： PMC3396754 DOI： 10.1016/j.diagmicrobio.2012.05.001

Source DB: PubMed Journal: Diagn Microbiol Infect Dis ISSN： 0732-8893 Impact factor: 2.803

20 in total

Review 1. Therapeutic outcome in invasive aspergillosis.

Authors: D W Denning
Journal: Clin Infect Dis Date: 1996-09 Impact factor: 9.079

2. Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET).

Authors: Peter G Pappas; Barbara D Alexander; David R Andes; Susan Hadley; Carol A Kauffman; Alison Freifeld; Elias J Anaissie; Lisa M Brumble; Loreen Herwaldt; James Ito; Dimitrios P Kontoyiannis; G Marshall Lyon; Kieren A Marr; Vicki A Morrison; Benjamin J Park; Thomas F Patterson; Trish M Perl; Robert A Oster; Mindy G Schuster; Randall Walker; Thomas J Walsh; Kathleen A Wannemuehler; Tom M Chiller
Journal: Clin Infect Dis Date: 2010-04-15 Impact factor: 9.079

3. Antigen detection in the diagnosis and management of a patient with probable cerebral aspergillosis treated with voriconazole.

Authors: M Machetti; M Zotti; L Veroni; N Mordini; M T Van Lint; A Bacigalupo; D Paola; C Viscoli
Journal: Transpl Infect Dis Date: 2000-09 Impact factor: 2.228

4. Aspergillus galactomannan antigen in the cerebrospinal fluid of bone marrow transplant recipients with probable cerebral aspergillosis.

Authors: Claudio Viscoli; Marco Machetti; Paola Gazzola; Andrea De Maria; Dimitri Paola; Maria Teresa Van Lint; Francesca Gualandi; Mauro Truini; Andrea Bacigalupo
Journal: J Clin Microbiol Date: 2002-04 Impact factor: 5.948

Review 5. Aspergillosis case-fatality rate: systematic review of the literature.

Authors: S J Lin; J Schranz; S M Teutsch
Journal: Clin Infect Dis Date: 2001-01-26 Impact factor: 9.079

6. Central nervous system lesions in liver transplant recipients: prospective assessment of indications for biopsy and implications for management.

Authors: C A Bonham; E A Dominguez; M B Fukui; D L Paterson; G A Pankey; M M Wagener; J J Fung; N Singh
Journal: Transplantation Date: 1998-12-27 Impact factor: 4.939

7. Combination antifungal therapy for invasive aspergillosis.

Authors: Kieren A Marr; Michael Boeckh; Rachel A Carter; Hyung Woo Kim; Lawrence Corey
Journal: Clin Infect Dis Date: 2004-08-27 Impact factor: 9.079

8. Voriconazole concentrations in the cerebrospinal fluid and brain tissue of guinea pigs and immunocompromised patients.

Authors: Irja Lutsar; Sarah Roffey; Peter Troke
Journal: Clin Infect Dis Date: 2003-08-07 Impact factor: 9.079

9. Pharmacokinetics and safety of intravenous voriconazole in children after single- or multiple-dose administration.

Authors: Thomas J Walsh; Mats O Karlsson; Timothy Driscoll; Adriano G Arguedas; Peter Adamson; Xavier Saez-Llorens; Ajay J Vora; Antonio C Arrieta; Jeffrey Blumer; Irja Lutsar; Peter Milligan; Nolan Wood
Journal: Antimicrob Agents Chemother Date: 2004-06 Impact factor: 5.191